• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同 ESKAPE 病原体中的差异抗微生物次生代谢产物解释了它们在医院环境中的适应性。

Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.

机构信息

Department of Biochemistry, Central University of Rajasthan, Bandarsindri, Ajmer, -305817, India.

Department of Biochemistry, Central University of Rajasthan, Bandarsindri, Ajmer, -305817, India.

出版信息

Infect Genet Evol. 2018 Dec;66:57-65. doi: 10.1016/j.meegid.2018.09.010. Epub 2018 Sep 15.

DOI:10.1016/j.meegid.2018.09.010
PMID:30227225
Abstract

Nosocomial infections are caused by ESKAPE (E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and E. cloacae) pathogens, and their co-existence is associated with their ability to survive in the hospital setup. They may produce molecules, which helps in the better survival of one ESKAPE pathogens over other. We have identified all secondary metabolite gene clusters in six ESKAPE pathogens and predicted antimicrobial and anti-biofilm properties of their product secondary metabolites. To validate our model, we have taken the secondary metabolites of ESKAPE pathogens and studied their interaction with diguanylate cyclase (involved in quorum sensing) and biofilm-associated protein (involved in biofilm formation) of Acinetobacter baumannii. Results suggest the presence of differential secondary metabolites in all ESKAPE pathogens with only three common non-antimicrobial secondary metabolites. Out of twenty-three antimicrobial secondary metabolites, TP-1161, nosiheptide and meilingmycin, showed the best antimicrobial activity and nineteen showed high anti-biofilm activity. Interaction study showed that secondary metabolites produced by other ESKAPE pathogens (non-Acinetobacter) have very good interaction with diguanylate cyclase and biofilm-associated protein of A. baumannii. This concludes that better survival of these ESKAPE pathogens in hospital setup can be correlated with differential production of antimicrobial secondary metabolites. The present study also investigates the molecular mechanism of the competition of different pathogens living in similar hospital setup (similar habitat). Therefore, the present study will initiate research that might lead to the discovery of antibiotics from one ESKAPE pathogen that controls the infection of other ESKAPE pathogens or other pathogens.

摘要

医院获得性感染是由 ESKAPE(屎肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和阴沟肠杆菌)病原体引起的,它们的共存与其在医院环境中生存的能力有关。它们可能产生有助于一种 ESKAPE 病原体比其他病原体更好地生存的分子。我们已经确定了六种 ESKAPE 病原体中的所有次级代谢物基因簇,并预测了它们产物次级代谢物的抗菌和抗生物膜特性。为了验证我们的模型,我们已经提取了 ESKAPE 病原体的次级代谢物,并研究了它们与鲍曼不动杆菌的二鸟苷酸环化酶(参与群体感应)和生物膜相关蛋白(参与生物膜形成)的相互作用。结果表明,所有 ESKAPE 病原体中都存在差异次级代谢物,只有三种常见的非抗菌次级代谢物。在二十三种抗菌次级代谢物中,TP-1161、诺西肽和美满霉素表现出最好的抗菌活性,十九种表现出高抗生物膜活性。相互作用研究表明,其他 ESKAPE 病原体(非鲍曼不动杆菌)产生的次级代谢物与鲍曼不动杆菌的二鸟苷酸环化酶和生物膜相关蛋白有很好的相互作用。这表明这些 ESKAPE 病原体在医院环境中更好的生存能力可以与抗菌次级代谢物的差异产生相关。本研究还研究了生活在类似医院环境(相似栖息地)中的不同病原体之间竞争的分子机制。因此,本研究将启动从一种 ESKAPE 病原体中发现控制其他 ESKAPE 病原体或其他病原体感染的抗生素的研究。

相似文献

1
Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.不同 ESKAPE 病原体中的差异抗微生物次生代谢产物解释了它们在医院环境中的适应性。
Infect Genet Evol. 2018 Dec;66:57-65. doi: 10.1016/j.meegid.2018.09.010. Epub 2018 Sep 15.
2
Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.羧酸类诺氟沙星盐可抑制 ESKAPE 病原体的浮游和生物膜生长模式。
J Appl Microbiol. 2018 Feb;124(2):408-422. doi: 10.1111/jam.13651.
3
Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.大肠埃希菌和 ESKAPE 病原体 GroES/GroEL 的功能差异。
mBio. 2021 Jan 12;12(1):e02167-20. doi: 10.1128/mBio.02167-20.
4
Detection of ESKAPE Bacterial Pathogens at the Point of Care Using Isothermal DNA-Based Assays in a Portable Degas-Actuated Microfluidic Diagnostic Assay Platform.在便携式脱气驱动微流控诊断检测平台上,使用基于等温DNA的检测方法在护理点检测ESKAPE细菌病原体。
Appl Environ Microbiol. 2017 Feb 1;83(4). doi: 10.1128/AEM.02449-16. Print 2017 Feb 15.
5
Dramatic increase in antimicrobial resistance in ESKAPE clinical isolates over the 2010-2020 decade in India.在过去的十年(2010 年至 2020 年),印度 ESKAPE 临床分离株的抗菌药物耐药性急剧增加。
Int J Antimicrob Agents. 2024 May;63(5):107125. doi: 10.1016/j.ijantimicag.2024.107125. Epub 2024 Feb 29.
6
In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.针对ESKAPE病原体对美国食品药品监督管理局(FDA)批准的文库进行体外筛选。
Curr Pharm Des. 2017;23(14):2147-2157. doi: 10.2174/1381612823666170209154745.
7
In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens.在ESKAPE病原体中,周期性氨基糖苷类药物挑战后体外高持久性的出现
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4630-7. doi: 10.1128/AAC.00757-16. Print 2016 Aug.
8
Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.印度南部一家三级护理中心的一些 ESKAPE 病原体的质粒图谱。
Indian J Med Res. 2019 Feb;149(2):222-231. doi: 10.4103/ijmr.IJMR_2098_17.
9
Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.人唾液蛋白组蛋白5对ESKAPE病原体具有强大的杀菌活性。
Front Cell Infect Microbiol. 2017 Feb 15;7:41. doi: 10.3389/fcimb.2017.00041. eCollection 2017.
10
Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.ESKAPE 病原体的应对策略:动物感染模型开发的注意事项和考虑因素。
ACS Infect Dis. 2024 Jul 12;10(7):2336-2355. doi: 10.1021/acsinfecdis.4c00007. Epub 2024 Jun 12.

引用本文的文献

1
Bacillibactin, a Potential -Based Antibacterial Non-Ribosomal Peptide: In Silico Studies for Targeting Common Fish Pathogens.杆菌铁载体,一种基于电位的抗菌非核糖体肽:针对常见鱼类病原体的计算机模拟研究
Int J Mol Sci. 2025 Jun 17;26(12):5811. doi: 10.3390/ijms26125811.
2
sp. VITGV156 secondary metabolite binds pathogenic protein PBP2a and Beta-lactamase.物种VITGV156的次生代谢产物与致病蛋白PBP2a和β-内酰胺酶结合。
Front Bioinform. 2025 Mar 26;5:1544800. doi: 10.3389/fbinf.2025.1544800. eCollection 2025.
3
Silver/Graphene Oxide Nanostructured Coatings for Modulating the Microbial Susceptibility of Fixation Devices Used in Knee Surgery.
银/氧化石墨烯纳米结构涂层用于调节膝关节手术固定装置的微生物敏感性。
Int J Mol Sci. 2023 Dec 23;25(1):246. doi: 10.3390/ijms25010246.
4
A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity.一种抗菌肽的设计类似物——蟹肌肽,具有增强的抗增殖和体内抗菌活性。
Int J Mol Sci. 2023 Sep 23;24(19):14472. doi: 10.3390/ijms241914472.
5
Biosynthetic gene cluster signature profiles of pathogenic Gram-negative bacteria isolated from Egyptian clinical settings.从埃及临床环境中分离出的致病性革兰氏阴性菌的生物合成基因簇特征图谱。
Microbiol Spectr. 2023 Sep 14;11(5):e0134423. doi: 10.1128/spectrum.01344-23.
6
Design of novel hybrid secondary metabolite targets to diguanylate cyclase of .新型杂合次级代谢产物靶向[具体对象]二鸟苷酸环化酶的设计
FEMS Microbes. 2021 Nov 22;2:xtab017. doi: 10.1093/femsmc/xtab017. eCollection 2021.
7
Assessment of potassium ion channel during electric signalling in biofilm formation of for finding antibiofilm molecule.在生物膜形成的电信号传导过程中评估钾离子通道以寻找抗生物膜分子。
Heliyon. 2023 Jan 5;9(1):e12837. doi: 10.1016/j.heliyon.2023.e12837. eCollection 2023 Jan.
8
Investigating the Toxicity of Compounds Yielded by on Vero Cells.研究由 产生的化合物对 Vero 细胞的毒性。
Toxins (Basel). 2022 Oct 18;14(10):712. doi: 10.3390/toxins14100712.
9
Inosine and D-Mannose Secreted by Drug-Resistant Affect Viability of Lung Epithelial Cells.耐药菌分泌的肌苷和 D-甘露糖影响肺上皮细胞的活力。
Molecules. 2022 May 6;27(9):2994. doi: 10.3390/molecules27092994.
10
Antibacterial and antitumor activities of a lectin-rich preparation from rhizome.来自根茎的富含凝集素制剂的抗菌和抗肿瘤活性。
Curr Res Pharmacol Drug Discov. 2022 Feb 17;3:100093. doi: 10.1016/j.crphar.2022.100093. eCollection 2022.